---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-22-000948"
form_type: "8-K"
ticker: "UTMD"
cik: "0000706698"
company_name: "UTAH MEDICAL PRODUCTS INC"
filed_at: "2022-04-27T23:59:59+00:00"
generated_at: "2026-06-26T04:17:27.537131+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# UTMD Q1 2022 revenue +12.4%, EPS +16.6%; operating margin expands to 36.7%

## Summary
- Revenue $12.3M, up 12.4% YoY; domestic sales +18%, OUS +4% (constant currency +7%).
- Net income $3.53M (+16.9%); diluted EPS $0.96 vs $0.82 in Q1 2021.
- Gross margin contracted to 61.1% from 63.4% on higher raw material and freight costs.
- Cash and investments $65.9M at Mar 31, 2022, up from $61.0M at Dec 31, 2021.
- No regular dividend paid in Q1 2022; special $2.00/share dividend was paid in Dec 2021.

## SEC filing metadata
- accession: 0001096906-22-000948
- form_type: 8-K
- ticker: UTMD
- cik: 0000706698
- company_name: UTAH MEDICAL PRODUCTS INC
- filed_at: 2022-04-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01, 99.1
- EDGAR index: https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/0001096906-22-000948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/utmd-20220426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-22-000948
- JSON: https://secwatch.observer/filing/0001096906-22-000948.json
- Plain text: https://secwatch.observer/filing/0001096906-22-000948.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.